Hydrocodone Bitartrate/Homatropine Methylbromide Tablets CII
Generic Name and Formulations:
Hydrocodone bitartrate 5mg, homatropine methylbromide 1.5mg; tabs.
Various generic manufacturers
Indications for Hydrocodone Bitartrate/Homatropine Methylbromide Tablets:
≥12yrs: 1 tab every 4–6hrs as needed; max 6 tabs/24hrs.
<6yrs: not recommended. 6–11yrs: ½ tab every 4–6hrs as needed; max 3 tabs/24hrs.
Risks from concomitant benzodiazepines or other CNS depressants (see Interactions). Risk of life-threatening respiratory depression (esp. in children). Abuse potential (monitor). Head injury, other intracranial lesions or pre-existing increase in intracranial pressure. Acute abdomen. Hypothyroidism. Addison's disease. Prostatic hypertrophy. Urethral stricture. Asthma. Narrow-angle glaucoma. Severe hepatic or renal impairment. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Increased risk of respiratory depression, sedation with benzodiazepines or other CNS depressants (eg, opioids, antihistamines, antipsychotics, anxiolytics, alcohol); avoid. May affect or be affected by MAOIs, TCAs.
Respiratory depression, drowsiness, hypertension, orthostatic hypotension, palpitations, anticholinergic effects, sedation, anxiety, nausea, rash, pruritus.
Formerly known under the brand name Hycodan.